|
FANCF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.384600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.658900E-03 |
| Normal-vs-Stage2 |
1.339190E-01 |
| Normal-vs-Stage3 |
3.442900E-04 |
| Normal-vs-Stage4 |
9.95590000000268E-05 |
| Stage1-vs-Stage2 |
2.402800E-01 |
| Stage1-vs-Stage3 |
5.431700E-02 |
| Stage1-vs-Stage4 |
2.406300E-02 |
| Stage2-vs-Stage3 |
1.034030E-02 |
| Stage2-vs-Stage4 |
2.763400E-03 |
| Stage3-vs-Stage4 |
4.140200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.973000E-04 |
| Normal-vs-AfricanAmerican |
2.112100E-02 |
| Normal-vs-Asian |
3.567800E-02 |
| Caucasian-vs-AfricanAmerican |
7.757800E-01 |
| Caucasian-vs-Asian |
2.204000E-01 |
| AfricanAmerican-vs-Asian |
3.116600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.799000E-03 |
| Normal-vs-Female |
2.178500E-03 |
| Male-vs-Female |
6.846200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.658900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.363800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.539600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.970000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.848000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.900600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.261800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.858000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.808400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.194000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.133600E-02 |
| Classical-VS-Follicular |
1.149610E-01 |
| Classical-VS-Other |
6.993200E-01 |
| Classical-VS-Normal |
3.000100E-03 |
| Tall-VS-Follicular |
9.637600E-03 |
| Tall-VS-Other |
4.811800E-01 |
| Tall-VS-Normal |
2.823100E-04 |
| Follicular-VS-Other |
9.253600E-01 |
| Follicular-VS-Normal |
7.673800E-02 |
| Other-VS-Normal |
5.668600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.760150E-02 |
| Normal-vs-N1 |
5.82139999999454E-05 |
| N0-vs-N1 |
4.956300E-03 |
|
|
